Back to search
FDAFDA · Food and drugs·Recall number D-0332-2026

Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

Published February 11, 2026 · Recall initiated: December 22, 2025

Summary

FDA records drug Class I recall D-0332-2026, published February 11, 2026 and initiated December 22, 2025. Recalling firm: HANDELNINE GLOBAL LLC; Status: Ongoing; Reported quantity: 4 bottles /30 capsules each; Lot: Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: product found to contain lead.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
HANDELNINE GLOBAL LLC
Distributor
Product was distributed to one customer in NY.
Lot
Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313 recalled?

Yes. FDA published recall D-0332-2026 on February 11, 2026. Reported hazard: CGMP Deviations: product found to contain lead.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release